Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced screening and management for advanced HIV patients with cryptococcal disease prevention, TB treatment, and rapid ART initiation
PACTR201901672543518Recruiting
- Sponsor
- Médecins Sans Frontières
- Start
- Jul 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in human immunodeficiency virus infection (HIV), Tuberculosis (TB) and cryptococcosis (2 arms), sponsored by Médecins Sans Frontières. Primary endpoints: Retention in care at 6 months and Retention in care at 12 months. Started Jul 2018; status: recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)cryptococcosis
Beyond the preview
Go deeper on PACTR201901672543518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201901672543518.